X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs CIPLA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD CIPLA MERCK LTD/
CIPLA
 
P/E (TTM) x 48.5 39.2 123.8% View Chart
P/BV x 7.3 3.6 203.3% View Chart
Dividend Yield % 0.4 0.5 82.1%  

Financials

 MERCK LTD   CIPLA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
CIPLA
Mar-18
MERCK LTD/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,060663 159.9%   
Low Rs623479 130.1%   
Sales per share (Unadj.) Rs632.4189.0 334.6%  
Earnings per share (Unadj.) Rs45.717.6 259.8%  
Cash flow per share (Unadj.) Rs62.334.0 183.1%  
Dividends per share (Unadj.) Rs11.003.00 366.7%  
Dividend yield (eoy) %1.30.5 248.8%  
Book value per share (Unadj.) Rs388.8176.7 220.0%  
Shares outstanding (eoy) m16.60805.12 2.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.33.0 44.0%   
Avg P/E ratio x18.432.5 56.7%  
P/CF ratio (eoy) x13.516.8 80.5%  
Price / Book Value ratio x2.23.2 67.0%  
Dividend payout %24.117.1 141.1%   
Avg Mkt Cap Rs m13,969459,724 3.0%   
No. of employees `0001.623.6 6.7%   
Total wages/salary Rs m1,48726,901 5.5%   
Avg. sales/employee Rs Th6,631.96,446.1 102.9%   
Avg. wages/employee Rs Th939.21,139.4 82.4%   
Avg. net profit/employee Rs Th479.4600.0 79.9%   
INCOME DATA
Net Sales Rs m10,498152,193 6.9%  
Other income Rs m2423,577 6.8%   
Total revenues Rs m10,741155,769 6.9%   
Gross profit Rs m1,13528,264 4.0%  
Depreciation Rs m27613,228 2.1%   
Interest Rs m01,142 0.0%   
Profit before tax Rs m1,10217,470 6.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-28 0.0%   
Extraordinary Inc (Exp) Rs m0-775 0.0%   
Tax Rs m3432,501 13.7%   
Profit after tax Rs m75914,166 5.4%  
Gross profit margin %10.818.6 58.2%  
Effective tax rate %31.114.3 217.6%   
Net profit margin %7.29.3 77.7%  
BALANCE SHEET DATA
Current assets Rs m6,410108,141 5.9%   
Current liabilities Rs m8,82838,322 23.0%   
Net working cap to sales %-23.045.9 -50.2%  
Current ratio x0.72.8 25.7%  
Inventory Days Days5897 59.5%  
Debtors Days Days3874 51.6%  
Net fixed assets Rs m1,406109,411 1.3%   
Share capital Rs m1661,610 10.3%   
"Free" reserves Rs m6,286140,682 4.5%   
Net worth Rs m6,455142,292 4.5%   
Long term debt Rs m036,621 0.0%   
Total assets Rs m8,828228,606 3.9%  
Interest coverage xNM16.3-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.7 178.6%   
Return on assets %8.66.7 128.4%  
Return on equity %11.810.0 118.1%  
Return on capital %17.110.0 171.6%  
Exports to sales %8.332.8 25.3%   
Imports to sales %21.00-   
Exports (fob) Rs m86949,883 1.7%   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m95951,691 1.9%   
Fx outflow Rs m2,61221,033 12.4%   
Net fx Rs m-1,65330,658 -5.4%   
CASH FLOW
From Operations Rs m1,07014,628 7.3%  
From Investments Rs m-750-8,540 8.8%  
From Financial Activity Rs m-150-3,855 3.9%  
Net Cashflow Rs m1712,431 7.0%  

Share Holding

Indian Promoters % 0.0 16.0 -  
Foreign collaborators % 51.8 20.8 249.0%  
Indian inst/Mut Fund % 18.2 12.2 149.2%  
FIIs % 1.0 23.7 4.2%  
ADR/GDR % 0.0 1.1 -  
Free float % 29.1 26.2 111.1%  
Shareholders   28,591 161,166 17.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SUN PHARMA  WYETH LTD  PFIZER  GLENMARK PHARMA  SUVEN LIFE  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Up Over 240 Points; Rupee Touches Record Low(12:30 pm)

After opening the day in the green, stock markets in India have continued their momentum and are presently trading on a positive note.

Related Views on News

CIPLA Announces Quarterly Results (1QFY19); Net Profit Up 4.7% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, CIPLA has posted a net profit of Rs 4 bn (up 4.7% YoY). Sales on the other hand came in at Rs 39 bn (up 11.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 14, 2018 02:01 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS